Diwakar Kumar

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (8)

• Elucidation of DNA Primase as a Drug Target in Leishmania donovani: Structure‐Guided Inhibitor Identification and Biochemical Validation
  Chemical Biology & Drug Design 2026 DOI: 10.1111/cbdd.70362
  +Save
• Tracking the Trail of Monkeypox: From Origins to Outbreak Control
  Cell Biochemistry and Function 2026 DOI: 10.1002/cbf.70239
  +Save
• Development of a highly specific PrM-based diagnostic marker for dengue virus detection: minimizing cross-reactivity with other flaviviruses and SARS-CoV-2
  In Silico Research in Biomedicine 2026 DOI: 10.1016/j.insi.2026.100212
  +Save
• Unveiling potent anti-leishmanial agents: a QSAR exploration of diverse chemical scaffolds targeting Leishmania donovani amastigotes
  SAR and QSAR in Environmental Research 2025 DOI: 10.1080/1062936X.2025.2529866
  +Save
• Investigation on the Drug Release Efficacy of the Ibuprofen-Loaded ZIF-8/Fe3O4 NPs Nanocarrier
  ACS Omega 2024 DOI: 10.1021/acsomega.3c09135
  +Save
• Antiparasitic activity, DNA/BSA binding interaction, molecular docking and DFT studies of mesogenic l-leucine based Schiff base and its derivatize Cu(II) and Zn(II) complexes
  Journal of Molecular Structure 2024 DOI: 10.1016/j.molstruc.2024.137633
  +Save
• Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches
  Infection, Genetics and Evolution 2020 DOI: 10.1016/j.meegid.2020.104451
  +Save
• Evaluation of Flavonoids as 2019-nCoV Cell Entry Inhibitor Through Molecular Docking and Pharmacological Analysis
  2020 DOI: 10.26434/chemrxiv.12071508.v1
  +Save